Related Experiment Video

Updated: Mar 28, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K

RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway

Yu Yan1, Yugang Jiang1

  • 1Department of Neurosurgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.

International Journal of Molecular Medicine
|January 1, 2016
PubMed

Insights

Receptor for activated C kinase 1 (RACK1) interacts with contactin-2 (CNTN2), promoting glioma growth and inhibiting differentiation. This RACK1/CNTN2 axis activates key signaling pathways, offering a potential therapeutic target for gliomas.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Receptor for activated C kinase 1 (RACK1) and contactin-2 (CNTN2) show abnormal expression in gliomas.
  • The specific interaction and functional roles of RACK1 and CNTN2 in glioma progression are not well understood.

Purpose of the Study:

  • To investigate the interaction between RACK1 and CNTN2.
  • To examine the role of the RACK1/CNTN2/receptor tyrosine kinase (RTK)/Ras/mitogen-activated protein kinase (MAPK) axis in glioma growth and differentiation.

Main Methods:

  • Western blot analysis to assess protein expression in glioma tissues and cells.
  • Co-immunoprecipitation assay to confirm RACK1-CNTN2 interaction.
  • Gain-of-function and loss-of-function experiments (siRNA) to evaluate functional impacts.

Main Results:

  • RACK1 and CNTN2 expression is elevated in high-grade gliomas and reduced in low-grade gliomas.
  • RACK1 directly interacts with and upregulates CNTN2.
  • Both RACK1 and CNTN2 promote glioma cell proliferation, inhibit differentiation, and activate the RTK/Ras/MAPK pathway.
  • Knockdown of CNTN2 abrogated RACK1's effects on proliferation, differentiation, and pathway activation.

Conclusions:

  • RACK1 interacts with CNTN2, and RACK1's effects on glioma progression are mediated through CNTN2.
  • The RACK1/CNTN2/RTK/Ras/MAPK signaling axis is implicated in glioma pathogenesis.
  • This axis represents a potential therapeutic target for glioma treatment.

More Related Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

14.1K
Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

4.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K